Navigation Links
Cumberland Pharmaceuticals Announces Voluntary Recall of Acetadote® Vials
Date:12/30/2010

NASHVILLE, Tenn., Dec. 30, 2010 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it has implemented a recall of 6 lots of Acetadote® (acetylcysteine) Injection, the Company's injectable treatment to prevent or lessen liver injury after ingestion of a potentially toxic quantity of acetaminophen. Cumberland informed the U.S. Food and Drug Administration (FDA) of its plans to voluntarily recall these lots of Acetadote as a precautionary measure based on observed particulate matter found in a very small number of vials. The source of the particulate matter was from the glass vial produced by a former supplier. The recall, which is not being undertaken on the basis of any known adverse medical events, affects a limited supply of product.

"We are recalling certain lots manufactured by a previous packaging supplier as a precautionary measure, and believe the risk of any serious adverse medical events to be remote," said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. "As part of ongoing quality assessment, we switched to a new vial packaging supplier in August of 2009. Patient safety, as always, remains our highest priority, and we are committed to taking the necessary steps to proactively protect patients from the potential of any safety risks."

The product being recalled is Acetadote (acetylcysteine) Injection, 20% solution (200mg/mL) in 30 mL single dose glass vials, NDC 66220-107-30. The lot numbers being recalled are lots 090304 (expiration Feb 2011), 090331 (expiration Feb 2011), 090401 (expiration Mar 2011), 090511 (expiration Apr 2011), 090602 (expiration May 2011) and 090616 (expiration May 2011). This product was distributed to U.S. wholesalers and distributors nationwide.

To report adverse reactions or quality concerns, please contact Cumberland Pharmaceuticals via email at

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
2. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
3. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
4. Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
5. Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
6. Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
7. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
8. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
9. Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
10. Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application
11. Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... BILLERICA, Mass. , June 2, 2015 /PRNewswire/ ... of Merck KGaA of Darmstadt, ... technology that compacts dry powder cell culture media ... handling. The compacted media are therefore more convenient ... their upstream processes. Photo - ...
(Date:6/2/2015)... GATOS, Calif. , June 2, 2015 ... you to shift mental states in minutes; feeling more calm ... for the first time, the sleek and simple wearable is ... home, work, or while commuting. The neurosignaling device is operated ... you achieve calm or increase your energy level. ...
(Date:6/2/2015)... MADRID , June 2, 2015 /PRNewswire/ ... meeting annuale della American Society of Clinical Oncology    ... multicentrico di fase 3 SAR3007, resi noti dal dipartimento ... hanno evidenziato un significativo miglioramento della sopravvivenza libera da ... ) rispetto al trattamento con dacarbazina in pazienti con ...
Breaking Medicine Technology:EMD Millipore Introduces Compaction Technology to Improve Solubility and Facilitate Handling of Cell Culture Media Used in Biopharmaceutical Production 2EMD Millipore Introduces Compaction Technology to Improve Solubility and Facilitate Handling of Cell Culture Media Used in Biopharmaceutical Production 3Thync Launches First Wearable to Shift Your State of Mind 2Thync Launches First Wearable to Shift Your State of Mind 3Thync Launches First Wearable to Shift Your State of Mind 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 3PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 5PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 6
... Md., March 26, 2012 MedImmune announced today it ... Online (NIC Online), from March 26 – 28, 2012.  ... attendees will participate in live or archived sessions entirely ... on pediatric influenza vaccination and the safety and efficacy ...
... International, Inc., a leading global supplier of medical imaging ... is has contributed $5000 to the American Cancer Society ... Key Gala, that benefits the Boston Hope Lodge, and ... 29, 2012. "We are pleased to make ...
Cached Medicine Technology:MedImmune to Present Nine Abstracts Related to Influenza Vaccination at First Online National Immunization Conference 2Quest International Donates $5000 to the American Cancer Society 2
(Date:6/2/2015)... Olive Fertility Centre is ... first fertility clinic. Surrey is British Columbia’s ... community, with one of Canada’s most vibrant ... now patients from Surrey and the surrounding ... Vancouver or Burnaby for fertility treatments. With ...
(Date:6/2/2015)... TU-Automotive Detroit is the biggest dedicated ... speakers include senior execs from GM, Chrysler, Mercedes, Ford, ... a crucial status update on the automotive technology industry ... 24 hours to secure one of the remaining passes. ... for tomorrow. There are 70 sessions looking across the ...
(Date:6/2/2015)... June 02, 2015 Vancouver, BC ... iData Research ( http://www.idataresearch.com ), the bone graft ... bone matrices (DBM) over traditional allograft materials. Because ... and thus an increase in operation time, alternative ... market growth in these synthetic materials is partly ...
(Date:6/2/2015)... National Autism Resource has partnered with ... and development agency, to launch its new website and ... new website is designed to help parents ... with autism. The site will expand its product line ... resources, from easy to understand information and helpful links ...
(Date:6/2/2015)... 2015 ODU , a ... connector solutions and cable assemblies, is announcing its ... the US market. , ODU MINI-SNAP® ... The self- securing circular connector solution is ideal ... require significant customization such as: sensor devices, data ...
Breaking Medicine News(10 mins):Health News:Olive Fertility Centre Opens First Fertility Clinic in Surrey BC 2Health News:The Connected Car’s Biggest Event is Here – TU-Automotive Detroit 2015 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 3Health News:National Autism Resources Launches New Website, Delivering More Products and Services 2Health News:National Autism Resources Launches New Website, Delivering More Products and Services 3Health News:ODU Announces ODU MINI-SNAP® - Advanced Circular Connector Solution for Highly Customizable Applications 2
... injuries in people, doctors monitor blood level increases of ... the severity of the injury. Creatinine is filtered by ... early damage to vital kidney function. For pets suffering ... found that even tiny increases of creatinine in blood ...
... Dec. 19 (HealthDay News) -- Blood pressure changes in middle ... stroke, a new study suggests. U.S. researchers analyzed data ... for an average of 14 years. People who kept ... 55 had the lowest lifetime risk (22 percent to 41 ...
... MONDAY, Dec. 19 (HealthDay News) -- ,A new study finds ... one of the most aggressive forms of skin cancer. The ... Cutaneous melanoma is the fifth most commonly diagnosed cancer in ... U.S. women. Incidence of the cancer is increasing, and death ...
... Acupuncture significantly reduces levels of a protein in ... Medical Center (GUMC) have found. They say their animal ... many people receive from this ancient Chinese therapy., Published ... the researchers say that if their findings are ...
... molecules derived naturally in the body from a major ... acids [EETs]) are currently in clinical trials for the ... of researchers led by Dipak Panigrahy and Mark ... at the Institute for Systems Biology, Seattle; and Darryl ...
... called EETs currently under scrutiny as possible treatment targets ... the growth and spread of cancer, according to researchers at ... findings also raise the possibility that drugs that block EETs ... This study, led by Dipak Panigrahy, MD, of DF/CHCC and ...
Cached Medicine News:Health News:MU researchers find pet kidney injuries are similar to human kidney injuries 2Health News:Blood Pressure Control in Middle Age Can Lower Lifetime Heart Risk 2Health News:Previous Cancer May Up Melanoma Risk 2Health News:Acupuncture reduces protein linked to stress in first of its kind animal study 2Health News:Targeting EETs to treat cardiovascular disease may prove a double-edged sword 2Health News:Targeting EETs to treat cardiovascular disease may prove a double-edged sword 3
0.5 mm angled tip. Round knurled handle with dull finish. Tip angle: 130 degrees....
Angled for easy insertion into side port incision for manipulation of nucleus. Flat, paddle like tip for placement in groove to crack the nucleus for emulsification....
Straight shaft with 0.2 mm hour glass shape tip. Round knurled handle with dull finish. Manufactured in titanium....
Flattened paddle tip with generous surface area is ideal for manipulating tissue, rotating and cracking the nucleus. Round knurled handle....
Medicine Products: